Ixprim Effervescent (Tramadol Hydrochloride, Paracetamol)

Ixprim Effervescent, containing tramadol and paracetamol, is indicated for pain conditions where combined opioid and non‑opioid analgesia is required.

• Moderate to severe acute pain: provides rapid relief of pain intensity.
• Post‑operative pain: reduces pain after surgical procedures.
• Traumatic pain: alleviates pain resulting from injuries.

• Tramadol acts as a µ‑opioid receptor agonist and inhibits the reuptake of norepinephrine and serotonin, enhancing descending inhibitory pain pathways, while paracetamol exerts central COX inhibition leading to analgesic and antipyretic effects. The combination yields synergistic pain relief through both opioid and non‑opioid mechanisms.

Common Side Effects

• Nausea: mild to moderate feeling of sickness.
• Dizziness: transient light‑headedness.
• Constipation: reduced bowel movements.
• Headache: mild to moderate pain in the head.
• Dry mouth: reduced salivation.
• Sweating: increased perspiration.

Serious or Rare Side Effects

• Seizures: risk increased at high doses or with interacting drugs.
• Respiratory depression: slowed breathing, especially in opioid‑naïve patients.
• Allergic reactions: rash, urticaria, or anaphylaxis.
• Serotonin syndrome: agitation, hyperthermia, and neuromuscular abnormalities.
• Hepatic injury: elevated liver enzymes or jaundice.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Ixprim Effervescent, consider the following precautions:

• Assess pain severity: ensure opioid therapy is justified for the level of pain.
• Review respiratory history: avoid in patients with severe asthma or chronic obstructive pulmonary disease.
• Monitor for dependence: limit duration and assess for signs of misuse.
• Avoid concomitant MAO inhibitors: discontinue MAO inhibitors at least 14 days before use.
• Adjust in hepatic impairment: consider dose reduction or alternative therapy.
• Store at ambient temperature: keep in the original pack, protect from moisture.

Ixprim Effervescent may interact with several medicines. Review patient medication lists carefully.

Major Interactions (Avoid)

• MAO inhibitors: risk of serotonin syndrome.
• CNS depressants (benzodiazepines, alcohol): enhanced respiratory depression.
• SSRIs or SNRIs: increased risk of serotonin syndrome.
• CYP2D6 inhibitors (e.g., quinidine, fluoxetine): elevated tramadol plasma levels.
• Warfarin: possible increased bleeding tendency.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (carbamazepine, phenytoin): may reduce analgesic efficacy.
• Diuretics: may potentiate hypotensive effects of paracetamol.
• Rifampicin: may lower plasma concentrations of both components.